Title: The effects of HIV/AIDS on the clinical profile and outcomes post pericardiectomy of patients with constrictive pericarditis: a retrospective review
From: Cardiovascular Journal of Africa, Vol 30, Issue 5 September/October 2019
Published: 2019
Pages: 251–257
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-015
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-015
Objective: The clinical profile and surgical
outcomes of patients with constrictive
pericarditis were compared in HIV-positive and
-negative individuals.
Methods: This study was a retrospective analysis
of patients diagnosed with constrictive
pericarditis at Inkosi Albert Luthuli Central
Hospital, Durban, over a 10-year period
(2004–2014).
Results: Of 83 patients with constrictive
pericarditis, 32 (38.1%) were HIV positive.
Except for pericardial calcification, which was
more common in HIV-negative subjects (n= 15,
29.4% vs n = 2, 6.3%; p = 0.011), the clinical
profile was similar in the two groups. Fourteen
patients died preoperatively (16.9%) and three
died peri-operatively (5.8%).On multivariable
analysis, age (OR 1.17; 95% CI: 1.03–1.34; p =
0.02), serum albumin level (OR 0.63; 95% CI:
0.43–0.92; p = 0.016), gamma glutamyl
transferase level (OR 0.97; 95% CI: 0.94–0.1.0;
p = 0.034) and pulmonary artery pressure (OR
1.49; 95% CI: 1.07–2.08; p = 0.018) emerged as
independent predictors of pre-operative
mortality rate. Peri-operative complications
occurred more frequently in HIV-positive
patients [9 (45%) vs 6 (17.6%); p = 0.030].
Conclusions: Without surgery, tuberculous
constrictive pericarditis was associated with a
high mortality rate. Although peri-operative
complications occurred more frequently, surgery
was not associated with increased mortality
rates in HIV-positive subjects.
Title: Ellisras Longitudinal Study
2017: association of hypertension with
increasing levels of adiposity in 10- to
14-year-old boys and girls in the Eastern Cape
(ELS 31)
Authors: A Chungag, CM Tata, CR Sewani-Rusike, W
Nel, BN Nkeh-Chungag
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 258–261
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-017
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-017
Objectives: Previous studies suggest a strong
relationship between obesity and hypertension.
This study aimed at evaluating the prevalence of
hypertension and pre-hypertension in 10- to
14-year-old boys and girls in the Eastern Cape
Province of South Africa and to determine the
association between blood pressure parameters
and selected measures of adiposity.
Methods: A cross-sectional, school-based study
of 540 10-to14-year-old children from seven
schools in the Eastern Cape Province was carried
out. Anthropometry and blood pressure parameters
were determined.
Results: All measures of adiposity and blood
pressure were significantly higher in the girls
(p < 0.05). The prevalence of hypertension and
pre-hypertension was over 20 and 12%,
respectively. Systolic blood pressure and pulse
pressure were associated (r > 0.27; p < 0.05)
with increasing levels of adiposity.
Conclusion: This study highlights the importance
of weightcontrol strategies for the prevention
of hypertension in these adolescents and later
on in life.
Title: Ellisras Longitudinal Study
2017: patterns of physical activity in an urban
and rural setting among black South African
adults (ELS 23) Authors: Z Smart Mabweazara, L Lloyd
Leach, Mario Smith, Lungiswa Tsolekile, Thandi
Puoane
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019 Published: 2019
Pages: 262–267 Full text:
Click here to order » Full text:
Click here to read online » Full text:
Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-018 DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-018
Background: Understanding patterns of physical
activity among adults can lead to targeted
approaches to improve activity levels in the
African population. This study aimed to
determine whether age, gender, location and
employment status could predict physical
activity among rural and urban South African
adults, and to determine the participants’ risk
of developing cardiovascular disease (CVD).
Methods: A cross-sectional design was conducted
on 319 participants of mean age 57 ± 10.43
years. Participants were sampled using a
stratified random-sampling procedure from an
urban township in Langa, Western Cape Province,
and a rural township in Mt Frere, Eastern Cape
Province, South Africa. A researcher-generated
questionnaire was used to collect
sociodemographic and hysical activity data.
Linear regression analysis was used to test
predictive relationships.
Results: Gender and geographical location were
significant predictors (p = 0.001) of physical
activity. Rural participants engaged more in
physical activity (91.5%) than urban
participants (84.2%) and were more likely to
meet the physical activity recommendations to
promote cardiovascular fitness (p = 0.000). The
most frequent physical activities in rural
participants were walking (15.4%), household
chores (18.8%) and household chores + gardening
(15.4%). The most frequent physical activities
in urban participants were household chores
(34.2%), and household chores + walking (33.7%).
In terms of duration of physical activity, rural
participants spent longer periods engaging in
activities lasting up to two hours (21.4%),
compared to 5.9% in urban participants (p =
0.000).
Conclusions: Gender and geographical location
were significant predictors of physical activity
among black South African adults. Overall, rural
adults engaged in more physical activity than
urban-dwelling adults. Males also engaged in
more physical activity and at a higher intensity
than females. Most rural participants met the
American College of Sports Medicine
recommendations for cardiovascular fitness and
therefore were at minimal risk for developing
CVD compared to their urban counterparts.
Title: Effects of atorvastatin on
time-dependent change of fast sodium current in
simulated acute ischaemic ventricular myocytes
Authors: Hongshi Li, Zheng Wan, Xiaolong Li,
Tianming Teng, Xin Du, Jing Nie
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 268–274
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-021
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-021
Introduction: Our previous experiments showed
that the transient sodium current (INa) was
abnormally increased in early ischaemia and
atorvastatin could inhibit INa. The aim of this
study was to observe the time-dependent effects
of simulated ischaemia on INa and characterise
the direct effects of atorvastatin on ischaemic
INa.
Methods: Left ventricular myocytes were isolated
from Wistar rats and randomly divided into two
groups: a control group (normal to simulated
ischaemia) and a statin group (normal to
simulated ischaemia with 5 μmol/l atorvastatin).
The INa was recorded under normal conditions (as
baseline) by wholecell patch clamp and recorded
from three to 21 minutes in the next phase of
simulated ischaemic conditions.
Results: In the control group, normalised INa
(at –40 mV) was increased to the peak (1.15 ±
0.08 mA) at three minutes of ischaemia compared
with baseline (0.95 ± 0.04 mA, p < 0.01), it
subsequently returned to baseline levels at nine
and 11 minutes of ischaemia (0.98 ± 0.12 and
0.92 ± 0.12 mA, respectively), and persistently
decreased with prolonged ischaemic time. In the
statin group, there were no differences between
baseline and the early stages of ischaemia (0.97
± 0.04 mA at baseline vs 0.92 ± 0.12 mA in
ischaemia for three minutes, p > 0.05).
Conclusion: Our results suggest that, in the
early stages of ischaemia, changes in INa in
ventricular myocytes are time-dependent, showing
an initial increase followed by a decrease,
while atorvastatin inhibited the transient
increase in INa and made the change more
gradual.
Title: Effects of cardiopulmonary
bypass on dialysisdependent patients
Authors: Nursen Tanrıkulu, Baburhan Ozbek
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 275–278
Full text: Click here to order »
Full text:
Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-023
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-023
Background: End-stage renal disease is
considered an independent risk factor for early
and late survival after coronary artery bypass
grafting.
Methods: We retrospectively analysed patients
with dialysisdependent renal insufficiency who
had undergone coronary artery bypass surgery
between 2010 and 2017. Patients who were
operated with the assistance of cardiopulmonary
bypass (ONCAB) were in group 1 and those
operated with off-pump coronary artery bypass
surgery (OPCAB) were in group 2. We compared
peri-operative morbidity and mortality rates and
short-term results of the two groups.
Results: There were 74 patients in group 1 and
36 in group 2. Blood transfusion requirement,
drainage, need for intraaortic balloon pump and
duration of stay in intensive care unit was
statistically significantly higher in group 1 (p
< 0.05). Also, postoperative creatine kinase
(CK) and creatine kinasemuscle/ brain (CKMB)
values were statistically significantly higher
in group 1 (p = 0.003).
Conclusion: Coronary artery bypass grafting
under ONCAB was a potential risk for morbidity
and mortality in patients with end-stage renal
disease. Performing OPCAB surgery may improve
postoperative outcomes and should be kept in
mind as a surgical option.
Title: Long-term safety and efficacy
of alirocumab in South African patients with
heterozygous familial hypercholesterolaemia: the
ODYSSEY Open-Label Extension study
Authors: Dirk J Blom, Johannes Breedt, Lesley J
Burgess, Iftikhar O Ebrahim, Graham Ellis,
Prashilla Soma, Eugene van der Walt, Poobalan
Naidoo, Alet van Tonder, Frederick J Raal
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 279–284
Full text: Click here to order »
Full text:
Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-039
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-039
Background: Alirocumab reduces low-density
lipoprotein cholesterol (LDL-C) levels by up to
61%. The ODYSSEY Open-Label Extension study
investigated the effect of alirocumab in
patients with heterozygous familial
hypercholesterolaemia (HeFH) over 144 weeks.
Methods: Eligible patients with HeFH had
completed an earlier double-blind, randomised,
placebo-controlled parent study. Patients were
initiated on 75 mg alirocumab Q2W subcutaneous
(SC) unless baseline LDL-C was > 8.9 mmol/l, in
which case they received 150 mg alirocumab Q2W.
Dose titration to 150 mg Q2W was at the
investigator’s discretion. Results: The study
enrolled 167 patients and the parent study mean
(± SD) baseline LDL-C level was 3.65 ± 1.9
mmol/l. Mean LDL-C level was reduced by 48.7% at
week 144; mean on-treatment LDL-C was 2.30 ±
1.24 mmol/l. Eight patients reported
injection-site reactions, with one treatment
iscontinuation. Treatment emergent anti-drug
antibodies were identified in five patients but
these did not affect the efficacy.
Conclusion: Alirocumab effectively and safely
reduced LDL-C in these patients.
Title: Clinical outcome of
intracoronary versus intravenous high-dose bolus
administration of tirofiban in diabetic patients
undergoing primary percutaneous coronary
intervention
Authors: Ahmed A Ghonim, Abdalla Mostafa, Ahmed
Emara, Alaa S Algazzar, Mohammed A Qutub
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 285–289
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-027
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-027
Background: Previous trials remain inconsistent
regarding the advantages and hazards related to
intracoronary (IC) compared with intravenous
(IV) administration of thrombolytics. We aimed
to evaluate the safety and effectiveness of IC
versus IV tirofiban administration in diabetic
patients (DM) with acute ST-segment elevation
myocardial infarction (STEMI) during primary
percutaneous coronary intervention (PCI).
Methods: This trial included 95 patients who
were randomised to high-dose bolus plus a
maintenance dose of tirofiban administered
either IV or IC. The groups were compared for
the incidence of composite major adverse cardiac
events (MACE) at 30 days. Levels of cardiac
markers were recorded pre- and post-intervention
for myocardial perfusion.
Results: The MACE were not different between the
groups, but post-procedure myocardial blush
grade (MBG) 3 and thrombolysis in myocardial
infarction (TIMI) 3 flow were significant in the
IC group (p = 0.45, 0.21, respectively),
favouring the IC strategy. Peak values of both
creatine kinase-muscle/brain (CK-MB) and
high-sensitivity troponin T (hs-TnT) were
significantly lower in the IC group (155.68 ±
121, 4291 ± 334 ng/dl) versus the IV group
(192.4 ± 86, 5342 ± 286 ng/dl) (p = 0.021, p =
0.035, respectively). The peak value was
significantly lower in the IC group than the IV
group in terms of ST-segment resolution and
30-day left ventricular ejection fraction (LVEF)
(p = 0.016 and 0.023, respectively).
Conclusion: Thirty days post PCI, IC tirofiban
was more efficient in ameliorating blood flow in
the coronary arteries and myocardial tissue
perfusion in DM patients after STEMI despite
bleeding events, and MACE rates showed no
significant difference between the groups. The
IC group showed better improvement in LVEF.
Title: Renal denervation: dark past,
bright future?
Authors: Marshall Heradien, Felix Mahfoud, Doug
Hettrick, Paul Brink
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 290–296
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-045
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-045
Abstract: The purpose of this review is to
update the reader on the relevance of autonomic
nervous system imbalance in clinical cardiology.
Increased sympathetic tone associates with the
metabolic syndrome, hypertension and cardiac
arrhythmias. With the kidneys playing a pivotal
role in increased peripheral resistance, sodium
and water retention and other mechanisms, renal
denervation (RD) may theoretically restore
autonomic imbalance and improve cardiovascular
outcomes. Landmark RD trials and novel uses for
RD in cardiac arrhythmia management are
discussed.
Title: Familial
hypercholesterolaemia workshop for leveraging
point-of-care testing and personalised medicine
in association with the Lipid and
Atherosclerosis Society of Southern Africa
Authors: AD Marais, MJ Kotze, FJ Raal, AA Khine,
PJ Talmud, SE Humphries
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 297–304
Full text: Click here to order »
Full text: Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-055
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-055
Abstract: Familial hypercholesterolaemia (FH) is
a common autosomal dominantly inherited disorder
in which impaired clearance of plasma
low-density lipoprotein cholesterol causes
premature atherosclerotic vascular disease and
tendon xanthomata. This workshop aimed to
consolidate information on the diagnosis and
management of FH in South Africa. The genetic
causes include mutations in the LDL receptor,
apolipoprotein B100 and proprotein convertase
subtilisin/kexin type 9 (PCSK9). Additionally,
the concatenation of multiple gene variants can
result in polygenic FH. Therapeutic measures
include a healthy lifestyle, statins and
cholesterol-absorption inhibitors that will
achieve control of the dyslipidaemia in the
majority of cases. The recently introduced
monoclonal antibodies to PCSK9 can improve
achievement of target concentration in severe
cases. FH is present in all sectors of the South
African population but there is sparse
documentation in the indigenous African
populations. FH should be actively sought,
diagnosed and treated with judicious
pharmacotherapy and screening of relatives.
Title: PASCAR and WHF Cardiovascular
Diseases Scorecard project
Authors: Awad A Mohamed, Jean M Fourie, Wihan
Scholtz, Oana Scarlatescu, George Nel, Saad
Subahi
From: Cardiovascular Journal of Africa, Vol 30,
Issue 5 September/October 2019
Published: 2019
Pages: 305–310
Full text: Click here to order »
Full text:
Click here to read online »
Full text: Click here to read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2019-063
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2019-063
Abstract: On behalf of the World Heart
Federation, the Pan-African Society of
Cardiology (PASCAR) co-ordinated data collection
and reporting for the country-level
Cardiovascular Diseases (CVD) Scorecard to be
used in Africa. The objective of the scorecard
is to create a clear picture of the current
state of CVD prevention, control and management
per country for 12 African countries. The Sudan
Heart Society assisted PASCAR in collating and
verifying the data through Drs Awad Mohamed
(president, Sudan Heart Society) and Saad Subahi
(PASCAR president, based in Sudan). Based on the
data collected, we summarise the strengths,
threats, weaknesses and priorities identified,
which need to be considered in conjunction with
the associated sections provided in the
infographic published with this report. Data
sets used included open-source data from the
World Bank, World Health Organisation and
government publications.